calpain inhibitor 2 has been researched along with bevirimat in 1 studies
Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (bevirimat) | Trials (bevirimat) | Recent Studies (post-2010) (bevirimat) |
---|---|---|---|---|---|
68 | 0 | 13 | 110 | 5 | 42 |
Protein | Taxonomy | calpain inhibitor 2 (IC50) | bevirimat (IC50) |
---|---|---|---|
Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.552 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CH; Huang, L; Hung, HY; Kim, SY; Lee, KH; Qian, K | 1 |
1 other study(ies) available for calpain inhibitor 2 and bevirimat
Article | Year |
---|---|
New betulinic acid derivatives as potent proteasome inhibitors.
Topics: Antineoplastic Agents; Betulinic Acid; Chymotrypsin; Cysteine Proteinase Inhibitors; Drug Design; Inflammation; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Pentacyclic Triterpenes; Proteasome Inhibitors; Signal Transduction; Structure-Activity Relationship; Triterpenes | 2011 |